Discontinued But Not Forgotten: HCV Drugs That Did Not Make It

I find it useful to look back and review drug candidates that were stopped in development.  In case of insufficient efficacy, i.e., not enough of a VL reduction or early viral rebound, everyone can sympathize with the decision to discontinue a drug. More importantly, we want to learn about the Continue reading Discontinued But Not Forgotten: HCV Drugs That Did Not Make It→

And the Results are …Pending

The website “ClinicalTrials.gov” has become the first stop for many of us who need to check on trial activity of a particular drug.  All larger human Phase 2 – 4 trials are listed there in quite some detail.  While companies sometimes shy away from publishing full entry criteria or primary Continue reading And the Results are …Pending→